From identifying risk factors for extensively resistant Mycobacterium tuberculosis in Africa to developing novel therapeutics for systemic fungal diseases, our Division's investigators are advancing the study of infectious diseases and the pathogens that cause them through hands-on field work supporting basic science research as well as investigator-initiated and industry-sponsored clinical trials.

Research in the Einstein Division of Infectious Diseases spans a broad range of areas, with particular strengths in the areas of mycology, tuberculosis, HIV, parasitology, and pneumococcal infection.

Several faculty in the Division of Infectious Diseases are members of NIH-designated research centers, including the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore (ICTR). Additionally, our faculty physicians conduct innovative research to support and advance Einstein’s Global Health Center and Montefiore Medical Center's rapidly expanding program in solid organ and bone marrow transplantation, dedicated to the prevention and management of infectious diseases in transplant recipients as well as other immunocompromised hosts. The Montefiore Center for Positive Living/ID Clinic, one of the largest HIV/AIDS clinics in New York State, offers comprehensive HIV primary care, specialty services, and access to clinical trials to more than 2500 Bronx residents. Other investigators are leading the CDI Collaborative, an initiative to measure Clostridium difficile infection (CDI) and implement infection and environmental controls to reduce CDI in numerous acute care facilities throughout the Greater New York Region

Fellows and trainees are offered the unique opportunity to advance their interests by collaborating with any of the over 300 investigators of basic science laboratories inside and outside the Division.

The Bronx's immigrant-intensive population and Montefiore Medical Center's diverse patient mix provide a rich clinical and translational research base for a broad range of infectious disease issues including those concerning elderly people and immunocompromised patients, surgical complications, substance abuse, and infections that impose major public health burden such as such as AIDS, hepatitis, malaria, and tuberculosis.

Members of the Division serve as trainers on a number of NIH-sponsored T32 training grants in the areas of emerging infectious diseases and geographic medicine, AIDS and opportunistic infection.